The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s immunohistochemistry IHC market report forecasts the immunohistochemistry IHC market size to grow to $3.29 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Immunohistochemistry IHC Market Report 2023 – https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Immunohistochemistry IHC Market Size Forecast
The global immunohistochemistry IHC market is expected to grow from $2.23 billion in 2022 to $2.41 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global immunohistochemistry (IHC) market size is expected to grow to $3.29 billion in 2027 at a CAGR of 8.1%.

North America held the largest immunohistochemistry IHC market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Immunohistochemistry IHC Market Driver ­– Increase In The Prevalence Of Chronic Diseases
According to the Centres for Disease Control and Prevention, a US-based national public health body, approximately 37.3 million individuals will have diabetes in 2022, accounting for 11.3% of the US population. As a result, an increase in the incidence of chronic diseases is propelling the immunohistochemistry (IHC) market forward.

Request for A Sample Of The Global Immunohistochemistry IHC Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Key Immunohistochemistry IHC Market Trend – Technological Advancement
To strengthen their market position, major industry players are focusing on producing technologically advanced products. For example, Akoya Biosciences, Inc, a US-based firm that provides end-to-end solutions for high-parameter tissue analysis, announced its new multiplex detection kits based on Opal multiplex technology known as Akoya’s Opal Multiplex Detection Kits in April 2021. The opal multiplex technique detects numerous biomarkers in a single piece of tissue by using iterative single staining and heating-mediated removal of the primary stain. The Opal Multiplex Detection Kits from Akoya offer phenotypic scoring via signal amplification, reduced sample and reagent usage, the ability to evaluate 3 to 8 IHC targets and nuclear stains, and other advanced features.

Immunohistochemistry IHC Market Segment
1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Immunohistochemistry IHC Market Major Players and Strategies
Major players in the immunohistochemistry IHC market are Thermo Fisher Scientific, F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, and Abbott Laboratories.

TPL Path Labs was acquired for an unknown sum by StageBio, a US-based immunohistochemistry (IHC) startup, in October 2021. StageBio hopes to acquire a market edge by expanding its product portfolio in immunohistochemistry (IHC), clinical histopathology, and molecular pathology through this acquisition. TPL Path Labs GmbH is a company established in Germany that specialises in immunohistochemistry (IHC).

The Immunohistochemistry IHC Global Market Report 2023 covers regional data on immunohistochemistry IHC market size, immunohistochemistry IHC market trends and drivers, opportunities, strategies, and immunohistochemistry IHC market competitor analysis. The countries covered in the immunohistochemistry IHC market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Immunohistochemistry (IHC) is a diagnostic technique that uses antibody-antigen interaction to locate specific proteins and antigens in tissue sections. This interaction is visualised using either chromogenic detection with an enzyme-substrate or fluorescence detection with a fluorescent dye.

View More Reports Related To The Immunohistochemistry IHC Market –
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2023
Lateral Flow Immunoassay LFIA Based Rapid Test Global Market Report 2023
Immunofluorescence Assay Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: